FDA Approves Iloperidone (Fanapt) for Acute Treatment of Bipolar I Disorder

The FDA approved iloperidone for acute treatment of bipolar I disorder on April 02, 2024, according to Vanda Pharmaceuticals.

Related Keywords

,Mihaelh Polymeropoulos ,Rosarelis Torres ,Vanda Pharmaceuticals Recent News ,Drug Administration ,Vanda Pharmaceuticals ,Vanda Pharmaceuticals On ,Vanda Pharmaceutical ,Young Mania Rating Scale ,Clinical Global Impressions Severity ,Clinical Global Impression ,Mayo Clinic ,Vanda Pharmaceutical Fanapt ,Acute Treatment ,Vanda Pharmaceuticals Recent ,Bipolar Mania ,Earlier Decision ,Approves Schizophrenia ,Coral Route ,Accessed March ,Bipolar Disorder ,Bipolari Disorder ,Fda ,Iloperidone ,Iloperidone Bipolar Disorder ,